Do you recommend switching from a GLP-1 agonist to insulin in female patients with type 2 diabetes who are planning to become pregnant?
Community PollStarted
Do you recommend switching from a GLP-1 agonist to insulin in female patients with type 2 diabetes who are planning to become pregnant?
26 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Endocrinology · Michigan State University College of Human Medicine
Answered on
Animal studies have indicated a potential for reproductive toxicity at maternally toxic doses of Semaglutide, Dulaglutide and Exenatide.
Due to the paucity of data with Semaglutide and Human pregnancy, the manufacturer advises stopping the drug 2 months before conception.
However, in a multicentric st...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Endocrinology · MedStar Health
Answered on
The GLP-1 receptor agonist drugs are contraindicated in pregnancy (pregnancy category C). In women planning to get pregnant, who are on one of these drugs, I would consider switching to metformin if they are not already on it. Of course, insulin can be prescribed if necessary.
Join for free or sign in to see the full answer